PDS Biotechnology Corp Property, Plant and Equipment, Additions
PDS Biotechnology Corp (PDSB) reported Property, Plant and Equipment, Additions of $151.49 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes
us-gaap:PropertyPlantAndEquipmentAdditions · last filed 2025-03-27
- PDS Biotechnology Corp property, plant and equipment, additions for the quarter ending 2023-12-31 was $0.00.
- PDS Biotechnology Corp property, plant and equipment, additions for the quarter ending 2023-09-30 was $0.00.
- PDS Biotechnology Corp property, plant and equipment, additions for the quarter ending 2023-06-30 was $0.00.
- PDS Biotechnology Corp property, plant and equipment, additions for the quarter ending 2023-03-31 was $151.49K.
- PDS Biotechnology Corp property, plant and equipment, additions for fiscal 2024 was $151.49K.
| Period end | Property, Plant and Equipment, Additions 3 month | Property, Plant and Equipment, Additions 6 month | Property, Plant and Equipment, Additions 9 month | Property, Plant and Equipment, Additions 12 month |
|---|---|---|---|---|
| 2024-12-31 | $151.49K 10-K · filed 2025-03-27 | |||
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 derived: sum of 3 quarters · filed 2024-11-14 | $151.49K 10-Q · filed 2024-11-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $151.49K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $151.49K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $151.49K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |